1-{4-[(1-CYCLOBUTYL-4-PIPERIDINYL)OXY]PHENYL}-4-{[4-(METHYLSULFONYL)PHENYL]CARBONYL}PIPERAZINE AS HISTAMINE H3 ANTAGONIST - Patent 1851201

(19)

(11)

EP 1 851 201 A1

(12)

(43)	Date of publication:
	07.11.2007 Bulletin 2007/45

(21)	Application number: 06709850.9

(22)	Date of filing: 22.02.2006

(51)

International Patent Classification (IPC):

C07D 211/46^(2006.01)

A61K 31/4545^(2006.01)

(86)	International application number:
	PCT/GB2006/000617

(87)	International publication number:
	WO 2006/090142 (31.08.2006 Gazette 2006/35)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	HR

(30)

Priority:

24.02.2005 GB 0503846
22.04.2005 US 112048

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 ONN (GB)

(72)	Inventors:
	HANCOCK, Ashley Paul Stevenage, Hertfordshire SG1 2NY (GB) HODGSON, Simon Teanby Stevenage, Hertfordshire SG1 2NY (GB) VINADER BRUGAROLAS, Maria-Victoria Stevenage, Hertfordshire SG1 2NY (GB) WASHINGTON, Melanie Lee Stevenage, Hertfordshire SG1 2NY (GB)

(74)	Representative: Priestley, Ruth Elizabeth
	GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)

(54)	1-{4-[(1-CYCLOBUTYL-4-PIPERIDINYL)OXY]PHENYL}-4-{[4-(METHYLSULFONYL)PHENYL]CARBONYL}PIPERAZINE AS HISTAMINE H3 ANTAGONIST